NVNO Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Stats
Dagens volum	21 804.00
Gjennomsnittsvolum	130 001
Markedsverdi	67.25M
EPS	$0 ( 2024-02-29 )
Neste inntjeningsdato	( $-0.400 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.64
ATR14	$0.0300 (0.59%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-13	Alavi Hamed	Sell	8 334	Stock Options
2024-03-13	Alavi Hamed	Buy	8 334	Common Stock
2024-03-13	Alavi Hamed	Sell	8 334	Common Stock
2023-12-05	Glynn Craig	Buy	75 000	Stock Options
2023-12-05	Jenusaitis Matthew	Buy	13 856	Stock Options

INSIDER POWER
44.18
Last 98 transactions
Buy: 6 344 915 \| Sell: 2 475 147

Volum Korrelasjon

Lang: -0.12 (neutral)

Kort: 0.18 (neutral)

Signal:(44.937) Neutral

enVVeno Medical Korrelasjon

10 Mest positive korrelasjoner
LRMR	0.878
CFLT	0.862
TYRA	0.859
POWL	0.858
MPWR	0.844
SGMO	0.827
VEON	0.825
LBC	0.823
FWRG	0.82
REYN	0.817

10 Mest negative korrelasjoner
GRNA	-0.858
SGLY	-0.849
GIPR	-0.84
SGLB	-0.814
GROW	-0.811
ITRM	-0.803
DCRC	-0.801

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

enVVeno Medical Korrelasjon - Valuta/Råvare

0.24
( neutral )

0.35
( neutral )

0.00
( neutral )

0.36
( neutral )

-0.64
( weak negative )

-0.66
( moderate negative )

enVVeno Medical Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-546 000 (0.00 %)
EPS:	$-1.910

FY	2023
Omsetning:	$0
Bruttogevinst:	$-546 000 (0.00 %)
EPS:	$-1.910

FY	2022
Omsetning:	$0
Bruttogevinst:	$-525 000 (0.00 %)
EPS:	$-2.16

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-12.80

Financial Reports:

No articles found.

enVVeno Medical

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Sanntidsoppdatering for enVVeno Medical [NVNO]

Upcoming Earnings Alert